Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,817 | -7,866 | -4,695 | -2,381 | -652 |
| Depreciation Amortization | 356 | 903 | 663 | 447 | 223 |
| Income taxes - deferred | -273 | -78 | N/A | N/A | 0 |
| Accounts receivable | -209 | -5,150 | -5,709 | -4,801 | -1,728 |
| Other Working Capital | -2,369 | -5,373 | -3,798 | -3,368 | -1,985 |
| Other Operating Activity | 556 | 5,783 | 6,008 | 5,025 | 1,825 |
| Operating Cash Flow | $-4,755 | $-11,781 | $-7,531 | $-5,078 | $-2,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -532 | -1,467 | -402 | -250 | -42 |
| Net Acquisitions | N/A | -5,491 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -45 | N/A | N/A | N/A | 0 |
| Other Investing Activity | -45 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-578 | $-6,958 | $-402 | $-250 | $-42 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -30 | -65 | -16 | N/A | 0 |
| Common Stock Issued | N/A | 27,548 | 11,006 | 11,006 | 11,006 |
| Financing Cash Flow | $-30 | $27,484 | $10,991 | $11,006 | $11,006 |
| Exchange Rate Effect | 208 | -10 | 0 | 37 | 20 |
| Beginning Cash Position | 12,525 | 3,790 | 3,790 | 3,790 | 3,790 |
| End Cash Position | 7,371 | 12,525 | 6,849 | 9,506 | 12,458 |
| Net Cash Flow | $-5,154 | $8,734 | $3,058 | $5,716 | $8,667 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,755 | -11,781 | -7,531 | -5,078 | -2,317 |
| Capital Expenditure | -532 | -1,467 | -402 | -250 | -42 |
| Free Cash Flow | -5,287 | -13,249 | -7,932 | -5,328 | -2,359 |